PCSK9 Modulates Macrophage Polarization-Mediated Ventricular Remodeling after Myocardial Infarction

Feifei Wang, Min Li, Aidong Zhang, Hairui Li, Can Jiang, Jun GuoJournal of Immunology Research 2022 · DOI

TL;DR

This study reveals that PCSK9, a protein known for its role in cholesterol regulation, also plays a crucial role in the heart's response to injury after a heart attack. By modulating macrophage behavior, PCSK9 influences how the heart muscle repairs itself, suggesting PCSK9 inhibitors could be a therapeutic strategy for improving recovery from myocardial infarction.

What Problem Does This Paper Address?

Acute myocardial infarction (AMI), commonly known as a heart attack, leads to significant damage and can result in heart failure. The heart's repair process involves complex inflammatory responses, particularly from macrophages, which can either aid or hinder recovery. While PCSK9 inhibitors are increasingly used to manage high-risk cardiovascular patients by lowering LDL cholesterol, their direct impact on myocardial repair after AMI and the underlying molecular mechanisms remain unclear. This paper aims to bridge this knowledge gap by investigating PCSK9's role in the inflammatory and remodeling processes following a heart attack, specifically focusing on its interaction with macrophages.

Methods

The researchers employed a multi-faceted approach using both in vivo and in vitro models:

  • Animal Models: Wild-type (WT) and PCSK9-knockout (PCSK9-/-) mice were used to establish a myocardial infarction (MI) model by ligating the left anterior descending coronary artery.
  • Macrophage Depletion: To assess the role of macrophages, clodronate liposomes were administered to systemically deplete these immune cells.
  • Echocardiography: This non-invasive imaging technique was used to evaluate cardiac function, measuring parameters like left ventricular ejection fraction (LVEF) and left ventricular internal diameter (LVID).
  • Histological Analysis: TTC staining was used to quantify infarct size, while Masson trichrome staining assessed myocardial fibrosis. Hematoxylin and eosin (H&E) staining was used to visualize inflammatory cell infiltration.
  • Immunofluorescence and Immunohistochemistry: These techniques were used to identify and quantify specific macrophage subtypes (M1 and M2) by staining for markers like F4/80, iNOS (M1 marker), and CD206 (M2 marker).
  • Molecular Biology Techniques:
    • q-PCR: Used to measure mRNA expression levels of various genes, including inflammatory markers (IL-6, iNOS) and anti-inflammatory/reparative markers (TGF-β, CD206).
  • Western Blotting: Employed to assess protein expression levels of PCSK9, inflammatory markers (IL-6, iNOS), and components of the TLR4 signaling pathway (TLR4, MyD88, p-P65).
  • Cell Culture: Mouse RAW264.7 macrophage cell line was used to study PCSK9's effect on macrophage polarization in vitro. Cells were stimulated with LPS (to induce M1) or IL4 (to induce M2) and then treated with exogenous PCSK9.
  • TLR4 Inhibition: To investigate the role of the Toll-like receptor 4 (TLR4) pathway, a specific inhibitor (TAK-242) was used in cell culture experiments.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • PCSK9's Dual Role: Beyond its well-established role in cholesterol metabolism, PCSK9 emerges as a significant player in the inflammatory response following heart attacks.
  • Macrophage Polarization is Key: The study strongly suggests that PCSK9's impact on cardiac repair is mediated through its influence on macrophage polarization, shifting them towards a pro-inflammatory M1 phenotype.
  • PCSK9 Knockout is Protective: Mice lacking PCSK9 showed improved cardiac function, reduced infarct size, and less inflammation after a heart attack, highlighting PCSK9's detrimental role in this context.
  • TLR4 as a Mediator: The research identifies the TLR4/MyD88/NF-κB signaling pathway as a crucial mechanism through which PCSK9 exerts its pro-inflammatory effects on macrophages.
  • Therapeutic Potential: The findings open avenues for exploring PCSK9 inhibitors not just for cholesterol management but also as a strategy to enhance cardiac recovery after MI by modulating the immune response.

Key Results

  • Increased PCSK9 after AMI: PCSK9 protein and mRNA levels were significantly elevated in the hearts of mice after myocardial infarction. Higher PCSK9 levels correlated with poorer cardiac function (lower LVEF, higher LVIDs).
  • PCSK9 Knockout Improves Outcomes: PCSK9-/- mice exhibited significantly better cardiac function (higher LVEF and FS%), smaller infarct sizes, reduced myocardial fibrosis, and less inflammatory cell infiltration compared to WT mice after MI.
  • Macrophage Depletion Abolishes Benefits: Systemic depletion of macrophages using clodronate liposomes abolished the beneficial effects of PCSK9 knockout on cardiac repair, underscoring the critical role of macrophages.
  • PCSK9 Promotes M1 Polarization: In vivo and in vitro studies demonstrated that PCSK9 knockout promoted M2 macrophage polarization, while exogenous PCSK9 protein induced M1 polarization in macrophages, characterized by increased expression of IL-6 and iNOS.
  • TLR4 Pathway Activation: PCSK9 was found to upregulate the TLR4/MyD88/NF-κB pathway, which was implicated in PCSK9-induced M1 macrophage polarization. Inhibition of TLR4 reversed the pro-inflammatory effects of PCSK9 on macrophages.

Limitations and Future Work

  • Clinical Data Limitation: The authors acknowledge that the lack of clinical data from patients using PCSK9 inhibitors after AMI is a limitation. Future studies should focus on larger clinical trials.
  • PCSK9 Inhibitor Specificity: The current monoclonal antibodies targeting PCSK9 primarily reduce LDL and may not fully reflect the effects of small molecule inhibitors that could potentially impact PCSK9 levels more broadly. Future research should investigate PCSK9 small molecule inhibitors.
  • Cardiomyocyte Role: The role of PCSK9 in the function and adaptation of cardiomyocytes themselves, particularly under ischemic conditions, warrants further investigation. The authors propose using a macrophage/cardiomyocyte co-culture system under hypoxia.
  • TGF-β Discrepancy: While PCSK9 knockout led to improved cardiac repair, TGF-β expression was upregulated in PCSK9-/- mice, which was not entirely consistent with Masson staining results. Further experiments are planned to clarify the role of PCSK9 in TGF-β modulation of fibroblast phenotype and fibrosis.

Summary updated

Abstract

Our data suggested that PCSK9 modulated macrophage polarization-mediated ventricular remodeling after myocardial infarction.
BibTeX
@article{wang2022pcsk,
  author = {Feifei Wang and Min Li and Aidong Zhang and Hairui Li and Can Jiang and Jun Guo},
  title = {{PCSK9 Modulates Macrophage Polarization-Mediated Ventricular Remodeling after Myocardial Infarction}},
  journal = {Journal of Immunology Research},
  year = {2022},
  doi = {10.1155/2022/7685796},
}
Figure